Celator Raises $10 Million

Celator Pharmaceuticals Inc., an oncopharmaceutical company with offices in Vancouver and Princeton, N.J., has raised US$10 million in Series C funding. Return backers include Domain Associates, Quaker BioVentures, TL Ventures, Ventures West Management, GrowthWorks, the Business Development Bank of Canada and Healthstone Investment Ltd. Celator has now raised $57 million in total VC funding since 2003. www.celatorpharma.com